Sign in Create account

Advik Laboratories Ltd.

Healthcare · Pharmaceuticals & Biotechnology

BSE: 531686
₹2.08
▲ 0.00 (0.00%)
Sept. 28, 2026 · BSE · bse_bhavcopy
Quality
6/100
Weak
Valuation
—/100
Expensive
Momentum
25/100
Bearish

QVM read Weak on all three Quality Weak, Valuation Expensive, Momentum Bearish

Tradinity's own scoring, not a copy of any third party's -- see the Key Metrics section for the real ratios behind each number.

Key Metrics

Market Capitalization
₹4 Cr
PE (TTM)
Data unavailable.
Price to Book
58.0
PEG (TTM)
Data unavailable (needs 8 quarters of EPS).
Institutions holding %
Data unavailable.
Piotroski Score
Data unavailable.
Relative return vs Nifty50, qtr %
Data unavailable.
Relative return vs Sector, qtr %
-40.4
Free Cash Flow
₹-1 Cr
as of March 31, 2026
Industry median ₹-0 Cr (198 companies)
EPS Growth (YoY)
0.00%
as of June 30, 2026
Industry median 26.14% (180 companies)
Net Profit Growth (TTM)
0.70%
as of June 30, 2026
Industry median 6.21% (175 companies)
Operating Revenue Growth (TTM)
0.00%
as of June 30, 2026
Industry median 9.08% (175 companies)
Profit Growth (YoY)
18.60%
as of Dec. 31, 2024
Industry median 22.20% (176 companies)
Revenue Growth (YoY)
-42.58%
as of Sept. 30, 2018
Industry median 14.05% (173 companies)
Current Ratio
0.23
as of March 31, 2026
Industry median 1.84 (197 companies)
Debt to Equity
109.84
as of March 31, 2026
Industry median 0.14 (186 companies)
Interest Coverage
-889.00
as of June 30, 2026
Industry median 10.58 (182 companies)
Net Margin
-859.38%
as of Dec. 31, 2021
Industry median 9.35% (179 companies)
Operating Margin (EBIT)
-915.31%
as of Dec. 31, 2021
Industry median 14.22% (181 companies)
Operating Margin (TTM)
-49.53%
as of June 30, 2026
Industry median 12.41% (182 companies)
Return on Assets
-10.17%
as of March 31, 2026
Industry median 5.54% (180 companies)
Return on Capital Employed
-363.68%
as of March 31, 2026
Industry median 12.43% (181 companies)
Return on Equity
-1258.39%
as of March 31, 2026
Industry median 9.66% (179 companies)

Investment checklist

Tradinity's own yes/no questions with the rule stated beside each. “Items without enough data are left out, never counted as a No, and the totals count only answered questions. A summary of numbers on this page, not advice.

Financials

0 of 5 met
  • No Quality score is Strong (70 or more)
  • No Debt to equity is below 0.5 (109.84)
  • No Return on equity is 15% or more (-1258.4%)
  • No Net cash flow for the latest year is positive
  • No Cash from operations is higher than the year before

Ownership

1 of 3 met
  • No FII/FPI or DII holding rose in the latest quarter
  • Yes Promoter holding rose or was unchanged in the latest quarter
  • No Promoter pledge is 5% of their holding or less and not rising (16.0% pledged)

Peer comparison

0 of 3 met
  • No 1-year return beats the industry median
  • No Revenue growth beats the industry median
  • No Profit growth beats the industry median

Value and momentum

0 of 5 met
  • No Valuation score is Undervalued (70 or more)
  • No Momentum score is Bullish (70 or more)
  • No Price is above the 5, 10 and 20 day averages
  • No Price is above the 50, 100 and 200 day averages
  • No Latest candle has a bullish shape (hammer, dragonfly doji, white marubozu)

Price

Download CSV

PE/EPS use each quarter's real filed EPS only from 45 days after quarter-end (no look-ahead) against the raw close of the day. Price-to-book isn't a mode here: the feed has no dated share count, so there's no real history to chart.

Relative Returns (vs SENSEX)

Prices adjusted for splits and bonuses. * = a corporate action affecting this date could not be parsed and is not reflected.

Price range

Day return
0.0%
Low 2.0800 · High 2.0800
1W return
0.0%
Low 2.0800 · High 2.0800
1M return
4.5%
Low 1.9900 · High 2.0800
52W return
-40.4%
Low 1.9900 · High 2.0800
Lifetime High ₹17.5000 (Jan. 3, 2008)
Lifetime Low ₹0.3200 (Jan. 21, 2020)

Full price history and technicals →

Technicals

Full technicals, indicators & Volume/Delivery →

EMA & SMA

Bullish1
Bearish5
5D
2.2
10D
2.4
20D
2.7
50D
2.7
100D
2.3
200D
1.5

Delivery and volume

Day avg. delivery
100.0%
Week avg. delivery
100.0%
Month avg. delivery
100.0%

Week = 5 sessions, Month = 22 sessions ending the latest trading day — the same combined NSE+BSE delivery data as the table below, just summed.

Resistance and support

2.08
Pivot
First resistance2.08
Second resistance2.08
Third resistance2.08
First support2.08
Second support2.08
Third support2.08
Day RSI23.8
Day MFI72.4
Day MACD-0.22
Day MACD signal-0.05

Beta

1M—
3M—
1Y—
3Y—

Price change analysis

↑ 4.5%
Over 1 Month
LowHigh
1.992.08
↓ -40.4%
Over 3 Months
LowHigh
1.992.08
↓ -40.4%
Over 6 Months
LowHigh
1.992.08
↓ -40.4%
Over 1 Year
LowHigh
1.992.08
Legend Positive indicator Neutral indicator Negative indicator

Buy/Sell Zone

View Buy/Sell Zone →

Data unavailable (needs at least 2 historical quarters with both a filed EPS and a matching trading day).

Financials

View full financials, peers & valuation multiples →
Revenue (June 30, 2026)
₹— Cr
Net profit (June 30, 2026)
₹-0 Cr
Basic EPS (June 30, 2026)
₹-0.1200

Ranks #181 of 184 in Pharmaceuticals & Biotechnology by market cap -- full peer table on the Financials page.

Shareholding pattern / Ownership

Shareholding summary

Jun 2026
  • Promoter35.89%

Largest holders

Data unavailable.

Historical promoter holding

Promoters holdings were unchanged at 35.89% in Jun 2026 qtr

All shareholding details →

Deals (Bulk & Block)

All 33 deals, with filters and CSV →
DateClientDealActionQuantityPriceExchange
20 Jun 2022 GEETA GARG Bulk Buy 380,000 1.5900 BSE
20 Jun 2022 SNEHA GARG Bulk Buy 385,000 1.5900 BSE
20 Jun 2022 VIKAS LIFECARE LIMITED Bulk Sell 865,000 1.5900 BSE
12 Jul 2021 VIKAS LIFECARE LIMITED Bulk Buy 200,000 1.1100 BSE
12 Jul 2021 PATLIPUTRA INTERNATIONAL LIMITED Bulk Sell 221,945 1.1100 BSE
18 May 2017 ETHAN CONSTRUCTIONS PRIVATE LIMITED Bulk Sell 121,279 5.8000 BSE
18 May 2017 ZUBER TRADING LLP Bulk Buy 211,859 5.7600 BSE
31 Dec 2015 MAGAN MERCANTILE PVT LTD Bulk Buy 123,900 11.9900 BSE
31 Dec 2015 NIRVANA MALL MANAGEMENT CO PVT LTD Bulk Sell 164,900 12.0000 BSE
24 Jul 2012 SAMPARK SECURITIES PRIVATE LIMITED Bulk Buy 65,234 7.8500 BSE

All bulk and block deals →

Corporate Announcements

All 13 announcements, with search →

Exchange disclosures (NSE and BSE), most recent first.

DateCategoryAnnouncement
1 Oct 2026 AGM/EGM Advik Laboratories Ltd - 531686 - Shareholder Meeting / Postal Ballot-Scrutinizer''s Report
1 Oct 2026 Company Update Advik Laboratories Ltd - 531686 - Announcement under Regulation 30 (LODR)-Change in Directorate
1 Oct 2026 Company Update Advik Laboratories Ltd - 531686 - Announcement under Regulation 30 (LODR)-Appointment of Statutory Auditor/s
1 Oct 2026 Company Update Advik Laboratories Ltd - 531686 - Announcement under Regulation 30 (LODR)-Appointment of Statutory Auditor/s
1 Oct 2026 Company Update Advik Laboratories Ltd - 531686 - Announcement under Regulation 30 (LODR)-Change in Management
1 Oct 2026 Company Update Advik Laboratories Ltd - 531686 - Outcome Of The 32Nd Annual General Meeting Of The Company Held On Tuesday 29Th September, 2026
1 Oct 2026 Company Update Advik Laboratories Ltd - 531686 - Outcome Of The 32Nd Annual General Meeting Of The Company Held On Tuesday 29Th September, 2026
29 Sep 2026 AGM/EGM Advik Laboratories Ltd - 531686 - Shareholder Meeting / Postal Ballot-Outcome of AGM
6 Sep 2026 Company Update Advik Laboratories Ltd - 531686 - Announcement under Regulation 30 (LODR)-Newspaper Publication
5 Sep 2026 AGM/EGM Advik Laboratories Ltd - 531686 - Notice Of The 32Nd Annual General Meeting For The Financial Year 2025-26

All announcements →

SWOT

Tradinity's own rule-based read of the real ratios elsewhere on this page -- not a copy of any third party's, and never a forward-looking prediction.

Strengths

Data unavailable.

Weaknesses

  • Low Return on Equity (-1258.4%)
  • Thin net profit margin (-859.4%)
  • High financial leverage (Debt/Equity 109.84)
  • Tight liquidity (Current Ratio 0.23)
  • Declining revenue YoY (-42.6%)

Opportunities

  • RSI in oversold territory (23.8) -- a technical rebound zone

Threats

  • Down 40.4% over the past year
  • Weak interest coverage (-889.0x) -- limited cushion against rising rates

Board of directors and corporate information →

F&O

View F&O, Options & Backtest →

Data unavailable (no single-stock futures or options activity on record for this company).

Frequently asked questions about Advik Laboratories Ltd.

Where is the share price?

The price at the top of this page is the last traded price from exchange data; during market hours it refreshes on its own. The Chart & Technicals section has the full price history.

Where are the financial results?

The Financials page has quarterly and annual results, ratios, cash flow and the balance sheet, on a standalone or consolidated basis.

Who owns the company?

The Ownership section shows the latest shareholding pattern from exchange filings, with promoter, FII, DII and public holdings by quarter.

Does Tradinity give buy or sell advice?

No. The scores and checklist on this page are rule-based summaries of published figures, not recommendations. Tradinity is not a registered investment adviser.